We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Prestige Consumer (PBH) to Post Q2 Earnings: Things to Note
Read MoreHide Full Article
Prestige Consumer Healthcare Inc. (PBH - Free Report) is likely to register both top- and bottom-line growth when it reports second-quarter fiscal 2021 earnings on Nov 4, before the opening bell. The Zacks Consensus Estimate for revenues is pegged at $261.3 million, which indicates a rise of 10.1% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for earnings is currently pegged at 99 cents per share, indicating a rise of 26.9% from the year-ago quarter’s reported figure. The consensus mark has been steady over the past 30 days. The provider of healthcare and household cleaning products has a trailing four-quarter earnings surprise of 11.5%, on average.
Key Aspects to Note
Prestige Consumer’s performance in the fiscal second quarter is likely to have benefited from the company’s efficient brand-building strategies and market share gains across certain categories and brands.
The company continuously gains from a rise in sales of brands that are linked with consumers’ enhanced outdoor movement. It prides on having a strong portfolio of healthcare brands. Management’s growth initiatives are also inclined toward strengthening its presence in healthcare.
Prestige Consumer has also been benefiting from strong e-commerce operations for a while as more consumers are shifting to the online mode of shopping. In this context, the company’s multi-year e-commerce investments are yielding results.
However, we cannot ignore the headwinds emerging from operating amid the pandemic. This includes adverse impacts stemming from supply-chain delays, labor shortages and scarcity of raw materials. Any rise in input costs is also a concern. On its last earnings call, management had anticipated higher general and administrative expenses for the quarter in review.
Prestige Consumer Healthcare Inc. Price, Consensus and EPS Surprise
Our proven model does not conclusively predict an earnings beat for Prestige Consumer this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Prestige Consumer currently has a Zacks Rank #3 and an Earnings ESP of 0.00%.
Stocks With Favorable Combination
Here are some companies you may want to consider as our model shows that these have the right combination of elements to beat on earnings this reporting cycle:
Image: Bigstock
Prestige Consumer (PBH) to Post Q2 Earnings: Things to Note
Prestige Consumer Healthcare Inc. (PBH - Free Report) is likely to register both top- and bottom-line growth when it reports second-quarter fiscal 2021 earnings on Nov 4, before the opening bell. The Zacks Consensus Estimate for revenues is pegged at $261.3 million, which indicates a rise of 10.1% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for earnings is currently pegged at 99 cents per share, indicating a rise of 26.9% from the year-ago quarter’s reported figure. The consensus mark has been steady over the past 30 days. The provider of healthcare and household cleaning products has a trailing four-quarter earnings surprise of 11.5%, on average.
Key Aspects to Note
Prestige Consumer’s performance in the fiscal second quarter is likely to have benefited from the company’s efficient brand-building strategies and market share gains across certain categories and brands.
The company continuously gains from a rise in sales of brands that are linked with consumers’ enhanced outdoor movement. It prides on having a strong portfolio of healthcare brands. Management’s growth initiatives are also inclined toward strengthening its presence in healthcare.
Prestige Consumer has also been benefiting from strong e-commerce operations for a while as more consumers are shifting to the online mode of shopping. In this context, the company’s multi-year e-commerce investments are yielding results.
However, we cannot ignore the headwinds emerging from operating amid the pandemic. This includes adverse impacts stemming from supply-chain delays, labor shortages and scarcity of raw materials. Any rise in input costs is also a concern. On its last earnings call, management had anticipated higher general and administrative expenses for the quarter in review.
Prestige Consumer Healthcare Inc. Price, Consensus and EPS Surprise
Prestige Consumer Healthcare Inc. price-consensus-eps-surprise-chart | Prestige Consumer Healthcare Inc. Quote
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Prestige Consumer this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Prestige Consumer currently has a Zacks Rank #3 and an Earnings ESP of 0.00%.
Stocks With Favorable Combination
Here are some companies you may want to consider as our model shows that these have the right combination of elements to beat on earnings this reporting cycle:
The Estee Lauder Companies Inc. (EL - Free Report) currently has an Earnings ESP of +0.38% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Corteva, Inc. (CTVA - Free Report) currently has an Earnings ESP of +7.89% and a Zacks Rank of 3.
Tyson Foods, Inc. (TSN - Free Report) currently has an Earnings ESP of +19.13% and is Zacks #3 Ranked.